Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies

IRVING, Texas, and OSAKA, Japan, Oct. 14, 2021 /PRNewswire/ -- Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, and Ono Pharmaceutical Co., Ltd. ("Ono"), an R&D-oriented pharmaceutical company committed to novel drug...

from PR Newswire: https://ift.tt/3pgnm83